Amgen (AMGN) Return on Capital Employed (2009 - 2026)

Amgen's Return on Capital Employed history runs 17 years deep, the most recent figure standing at 15.87% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 486.0% year-over-year to 15.87%; the TTM figure through Mar 2026 stood at 15.87% (up 486.0% YoY), while the FY2025 annual figure was 13.82%, up 365.0% from the prior year.
• Return on Capital Employed was 15.87% for Q1 2026 at Amgen, up from 14.0% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 20.44% in Q3 2022 to a low of 8.79% in Q2 2024.
• Historically, Return on Capital Employed has averaged 13.55% across 5 years, with a median of 12.9% in 2025.
• The sharpest annual moves came in 2022 and 2023: Return on Capital Employed jumped 499 bps in 2022, then sank 917 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 19.63% in 2022, then tumbled by 47 bps to 10.47% in 2023, then increased by 2 bps to 10.63% in 2024, then soared by 32 bps to 14.0% in 2025, then grew by 13 bps to 15.87% in 2026.
• The last three Return on Capital Employed figures came in at 15.87% (Q1 2026), 14.0% (Q4 2025), and 12.9% (Q3 2025), per Business Quant data.